Rendering

Component: (Network and Table)
Network
100290 - Disclosure - Goodwill and In-Process Research and Development (Tables)
(http://www.abiomed.com/20160331/taxonomy/role/DisclosureGoodwillAndInProcessResearchAndDevelopmentTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000815094 (http://www.sec.gov/CIK)
Goodwill And Intangible Assets Disclosure [Abstract]Period [Axis]
2015-04-01 - 2016-03-31
Goodwill And Intangible Assets Disclosure [Abstract]
 
Goodwill Activity

The goodwill activity is as follows:

 

 

 

(in $000's)

 

Balance at March 31, 2014

 

$

37,990

 

Additions

 

 

1,964

 

Foreign currency translation impact

 

 

(8,420

)

Balance at March 31, 2015

 

$

31,534

 

Foreign currency translation impact

 

 

1,469

 

Balance at March 31, 2016

 

$

33,003

 

 

  
Carrying value of In-Process Research and Development

The carrying value of the Company’s IPR&D assets and the change in the balance for the fiscal years ended March 31, 2016 and 2015 is as follows:

 

 

 

(in $000's)

 

Balance at March 31, 2014

 

$

—

 

Additions

 

 

18,500

 

Foreign currency translation impact

 

 

(3,789

)

Balance at March 31, 2015

 

$

14,711

 

Foreign currency translation impact

 

 

685

 

Balance at March 31, 2016

 

$

15,396